Abstract
BackgroundAlthough medication of rheumatoid arthritis (RA) has been improved by positive administration of methotrexate and biological agents (BIO) for decades, treatment of concomitant disease in RA patients, such as osteoporosis,...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
